FIBRINOGEN - ANVISA Registration 81628880054

Access comprehensive regulatory information for FIBRINOGEN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81628880054 and manufactured by GUANGZHOU WONDFO BIOTECH CO. LTD. The registration is held by FIRSTLAB INDUSTRIA IMPORTACAO E EXPORTACAO DE PRODUTOS PARA LABORATORIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including BIOSYSTEMS S.A., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81628880054
Registration Details
ANVISA Registration Number: 81628880054
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Kit Fibrinogênio Point Of Care
Risk Class II

Registration Details

81628880054

25351272747202222

27089709000161

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Apr 20, 2022

VIGENTE

09/18/2025 19:00:01